Medtronic Inc. (MDT) unveiled details of its sale of nearly $1.08 billion of debt in two series of senior notes as the medical-devices maker raises funds for working capital and other purposes, which may include debt repayments.
Medtronic sold $675 million of 10-year notes priced to yield 3.161%, or 0.90 percentage points over Treasurys, and $400 million of 30-year notes priced to yield 4.51%, or 1.1 points over Treasurys. The pricing of each bond was 0.05 points tighter than earlier guidance, indicating broad demand.
Medtronic's debt sale is one of at least four sizable issues in the U.S. bond market Wednesday amid signs that investor demand for risky assets is holding up, particularly after the Federal Reserve indicated Tuesday most of the biggest U.S. banks passed the latest round of stress tests.
The company, which has continued to see challenges in its key cardiac rhythm and spine business, last month reported that its fiscal third-quarter earnings rose 1.2% thanks to fewer charges and the impact of shedding its Physio-Control business.
Shares were down 10 cents at $38.56 in recent trading.
-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com